# Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Cooperative Agreements for Prevention Research Centers, Program Announcement 01101
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting.
*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Cooperative Agreements for Prevention Research Centers, Program Announcement 01101, meeting.
*Times and Dates:* 8:30 a.m.-9 a.m., July 10, 2001 (Open).9 a.m.-5 p.m., July 10, 2001 (Closed).8:30 a.m.-12 noon, July 11, 2001 (Closed).
*Place:* Crowne Plaza Airport Hotel, 1325 Virginia Ave, Atlanta, GA 30344.
*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Deputy Director for Program Management, CDC, pursuant to Public Law 92-463.
*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of grant applications to fund two new Prevention Research Centers received in response to Program Announcement #01101.
*Contact Person for More Information:* John M. Davis, Public Health Analyst, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 4770 Buford Highway, m/s K46, Atlanta, GA, 30341. Telephone 770/488-5659, email [email protected].
The Director, Management Analysis and Services office has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Dated: June 20, 2001.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, CDC.